MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

DSpace Repository

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

Author: Sledge, George W., Jr.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Frenzel, Martin; Lin, Yong; Barriga, Susana; Smith, Ian C.; Bourayou, Nawel; Llombart-Cussac, Antonio
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Journal of Clinical Oncology (2017), Bd. 35, H. 25, S. 2875-
Verlagsangabe: Amer Soc Clinical Oncology
Language: English
Full text: http://dx.doi.org/10.1200/JCO.2017.73.7585
ISSN: 1527-7755
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)